BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 25849606)

  • 1. Functional characterization of putative novel splicing mutations in the cardiomyopathy-causing genes.
    Millat G; Lafont E; Nony S; Rouvet I; Bozon D
    DNA Cell Biol; 2015 Jul; 34(7):489-96. PubMed ID: 25849606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional Studies and In Silico Analyses to Evaluate Non-Coding Variants in Inherited Cardiomyopathies.
    Frisso G; Detta N; Coppola P; Mazzaccara C; Pricolo MR; D'Onofrio A; Limongelli G; Calabrò R; Salvatore F
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A molecular screening strategy based on beta-myosin heavy chain, cardiac myosin binding protein C and troponin T genes in Italian patients with hypertrophic cardiomyopathy.
    Girolami F; Olivotto I; Passerini I; Zachara E; Nistri S; Re F; Fantini S; Baldini K; Torricelli F; Cecchi F
    J Cardiovasc Med (Hagerstown); 2006 Aug; 7(8):601-7. PubMed ID: 16858239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Key Value of RNA Analysis of MYBPC3 Splice-Site Variants in Hypertrophic Cardiomyopathy.
    Singer ES; Ingles J; Semsarian C; Bagnall RD
    Circ Genom Precis Med; 2019 Jan; 12(1):e002368. PubMed ID: 30645170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole MYBPC3 NGS sequencing as a molecular strategy to improve the efficiency of molecular diagnosis of patients with hypertrophic cardiomyopathy.
    Janin A; Chanavat V; Rollat-Farnier PA; Bardel C; Nguyen K; Chevalier P; Eicher JC; Faivre L; Piard J; Albert E; Nony S; Millat G
    Hum Mutat; 2020 Feb; 41(2):465-475. PubMed ID: 31730716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Micro-exons of the cardiac myosin binding protein C gene: flanking introns contain a disproportionately large number of hypertrophic cardiomyopathy mutations.
    Frank-Hansen R; Page SP; Syrris P; McKenna WJ; Christiansen M; Andersen PS
    Eur J Hum Genet; 2008 Sep; 16(9):1062-9. PubMed ID: 18337725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac Troponin T (TNNT2) mutations are less prevalent in Indian hypertrophic cardiomyopathy patients.
    Rani DS; Nallari P; Dhandapany PS; Tamilarasi S; Shah A; Archana V; AshokKumar M; Narasimhan C; Singh L; Thangaraj K
    DNA Cell Biol; 2012 Apr; 31(4):616-24. PubMed ID: 22017532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variation screening of TNNT2 gene in a cohort of patients with hypertrophic and dilated cardiomyopathy.
    Jáchymová M; Muravská A; Paleček T; Kuchynka P; Řeháková H; Magage S; Král A; Zima T; Horký K; Linhart A
    Physiol Res; 2012; 61(2):169-75. PubMed ID: 22292720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic diagnosis of hypertrophic cardiomyopathy using mass spectrometry DNA arrays and high resolution melting.
    Santos S; Lança V; Oliveira H; Branco P; Silveira L; Marques V; Brito D; Madeira H; Bicho M; Fernandes AR
    Rev Port Cardiol; 2011 Jan; 30(1):7-18. PubMed ID: 21425739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening of MYH7, MYBPC3, and TNNT2 genes in Brazilian patients with hypertrophic cardiomyopathy.
    Marsiglia JD; Credidio FL; de Oliveira TG; Reis RF; Antunes Mde O; de Araujo AQ; Pedrosa RP; Barbosa-Ferreira JM; Mady C; Krieger JE; Arteaga-Fernandez E; Pereira Ada C
    Am Heart J; 2013 Oct; 166(4):775-82. PubMed ID: 24093860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of large gene deletions and duplications in MYBPC3 and TNNT2 in patients with hypertrophic cardiomyopathy.
    Bagnall RD; Yeates L; Semsarian C
    Int J Cardiol; 2010 Nov; 145(1):150-3. PubMed ID: 19666196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of pathogenic gene mutations in
    Ito K; Patel PN; Gorham JM; McDonough B; DePalma SR; Adler EE; Lam L; MacRae CA; Mohiuddin SM; Fatkin D; Seidman CE; Seidman JG
    Proc Natl Acad Sci U S A; 2017 Jul; 114(29):7689-7694. PubMed ID: 28679633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Splicing analysis of 26 F8 nucleotide variations using a minigene assay.
    Jourdy Y; Fretigny M; Nougier C; Négrier C; Bozon D; Vinciguerra C
    Haemophilia; 2019 Mar; 25(2):306-315. PubMed ID: 30690819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study of mutations causing hypertrophic cardiomyopathy in a group of patients from Espirito Santo, Brazil].
    Marsiglia JD; Batitucci Mdo C; Paula Fd; Barbirato C; Arteaga E; Araújo AQ
    Arq Bras Cardiol; 2010 Jan; 94(1):10-7. PubMed ID: 20414521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of a large MYBPC3 rearrangement in a cohort of 100 unrelated patients with hypertrophic cardiomyopathy.
    Chanavat V; Seronde MF; Bouvagnet P; Chevalier P; Rousson R; Millat G
    Eur J Med Genet; 2012 Mar; 55(3):163-6. PubMed ID: 22314326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional characterization of two novel splicing mutations in the OCA2 gene associated with oculocutaneous albinism type II.
    Rimoldi V; Straniero L; Asselta R; Mauri L; Manfredini E; Penco S; Gesu GP; Del Longo A; Piozzi E; Soldà G; Primignani P
    Gene; 2014 Mar; 537(1):79-84. PubMed ID: 24361966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of high-throughput targeted exome-sequencing to screen for copy number variation in hypertrophic cardiomyopathy.
    Lopes LR; Murphy C; Syrris P; Dalageorgou C; McKenna WJ; Elliott PM; Plagnol V
    Eur J Med Genet; 2015 Nov; 58(11):611-6. PubMed ID: 26455666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening BRCA1 and BRCA2 unclassified variants for splicing mutations using reverse transcription PCR on patient RNA and an ex vivo assay based on a splicing reporter minigene.
    Bonnet C; Krieger S; Vezain M; Rousselin A; Tournier I; Martins A; Berthet P; Chevrier A; Dugast C; Layet V; Rossi A; Lidereau R; Frébourg T; Hardouin A; Tosi M
    J Med Genet; 2008 Jul; 45(7):438-46. PubMed ID: 18424508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted next-generation sequencing (NGS) of nine candidate genes with custom AmpliSeq in patients and a cardiomyopathy risk group.
    Glotov AS; Kazakov SV; Zhukova EA; Alexandrov AV; Glotov OS; Pakin VS; Danilova MM; Poliakova IV; Niyazova SS; Chakova NN; Komissarova SM; Kurnikova EA; Sarana AM; Sherbak SG; Sergushichev AA; Shalyto AA; Baranov VS
    Clin Chim Acta; 2015 Jun; 446():132-40. PubMed ID: 25892673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mutations in genes for sarcomeric proteins].
    Kimura A
    Nihon Rinsho; 2000 Jan; 58(1):117-22. PubMed ID: 10885298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.